Trial Profile
EffectiveNess of VISanne in Improving Quality of Life in asIan wOmen With eNdometriosis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 May 2022
Price :
$35
*
At a glance
- Drugs Dienogest (Primary)
- Indications Endometriosis
- Focus Therapeutic Use
- Acronyms ENVISIOeN
- Sponsors Bayer
- 01 Apr 2022 Results published in the Reproductive Sciences
- 10 Jan 2019 Status changed from active, no longer recruiting to completed.
- 19 Sep 2016 Status changed from recruiting to active, no longer recruiting.